Sydney

Minera Salar Blanco, Agrees Strategic Alliance with Mitsui for the Development of Maricunga and Future Developments in Chile

Tuesday, May 11, 2021 - 1:14am

b'SYDNEY, Australia, May 11, 2021 (GLOBE NEWSWIRE) -- Lithium Power International Limited (ASX: LPI) (\xe2\x80\x9cLPI\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) is pleased to announce that its joint venture company, Minera Salar Blanco S.A. (\xe2\x80\x9cMSB\xe2\x80\x9d) has entered into a non-binding Memorandum of Understanding (the \xe2\x80\x9cMOU\xe2\x80\x9d) with the Japanese conglomerate Mitsui & Co., Ltd., (\xe2\x80\x9cMitsui\xe2\x80\x9d) to set up a strategic alliance to advance the development of the Maricunga project (the \xe2\x80\x9cProject\xe2\x80\x9d).\nThe MOU intends to create a partnership on the Project.

Key Points: 
  • b'SYDNEY, Australia, May 11, 2021 (GLOBE NEWSWIRE) -- Lithium Power International Limited (ASX: LPI) (\xe2\x80\x9cLPI\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) is pleased to announce that its joint venture company, Minera Salar Blanco S.A. (\xe2\x80\x9cMSB\xe2\x80\x9d) has entered into a non-binding Memorandum of Understanding (the \xe2\x80\x9cMOU\xe2\x80\x9d) with the Japanese conglomerate Mitsui & Co., Ltd., (\xe2\x80\x9cMitsui\xe2\x80\x9d) to set up a strategic alliance to advance the development of the Maricunga project (the \xe2\x80\x9cProject\xe2\x80\x9d).\nThe MOU intends to create a partnership on the Project.
  • The MOU is comprehensive, and it sets a framework for the Stage One of the Project development to proceed with the backing of a world-renowned partner.
  • The Project is in its first stage denominated the \xe2\x80\x9cStage One\xe2\x80\x9d with a nameplate capacity of 15,000 annual tonnes of high purity lithium carbonate (the \xe2\x80\x9cProducts\xe2\x80\x9d) over a 20-year mine life.
  • Mitsui has built a strong and diverse core business portfolio covering the Mineral and Metal Resources, Energy, Machinery and Infrastructure, and Chemicals industries.\nFor Australia\xc2\xa0and Asian investor relations enquiries:\nFor U.S.\xc2\xa0and other international investor relations enquiries:\nArrowhead Business and Investment Decisions, LLC\n'

Immutep Operational Update

Friday, May 7, 2021 - 1:00pm

Currently the trial has reached approximately 72% of events, indicating 72% of total patients with this late-stage cancer had been followed through until death.

Key Points: 
  • Currently the trial has reached approximately 72% of events, indicating 72% of total patients with this late-stage cancer had been followed through until death.
  • Currently, 27 patients of a total of 36 patients have received the first treatment.
  • Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders.
  • Immutep is also developing an agonist of LAG-3 (IMP761) for autoimmune disease.

Delaware Funds® by Macquarie Municipal Income Funds Announce Dividends

Tuesday, May 4, 2021 - 10:10pm

b'Macquarie Investment Management, a member of Macquarie Group, is a global asset manager with offices in the United States, Europe, Asia, and Australia.

Key Points: 
  • b'Macquarie Investment Management, a member of Macquarie Group, is a global asset manager with offices in the United States, Europe, Asia, and Australia.
  • Macquarie Investment Management is supported by the resources of Macquarie Group (ASX: MQG; ADR: MQBKY), a global provider of asset management, investment, banking, financial and advisory services.\nAdvisory services are provided by Macquarie Investment Management Business Trust, a registered investment advisor.
  • Macquarie Group refers to Macquarie Group Limited and its subsidiaries and affiliates worldwide.
  • The obligations of these entities do not represent deposits or other liabilities of MBL, a subsidiary of Macquarie Group Limited and an affiliate of Macquarie Investment Management.

Recce Pharmaceuticals Announces Positive Data on Bactericidal Activity of RECCE® 327 Against All Six ESKAPE Pathogens

Tuesday, May 4, 2021 - 1:00pm

\xe2\x80\x9cAntimicrobial resistance is one of the most urgent threats to global public health with the suite of ESKAPE pathogens posing a significant threat due to their virulence and rapid development of drug-resistance.

Key Points: 
  • \xe2\x80\x9cAntimicrobial resistance is one of the most urgent threats to global public health with the suite of ESKAPE pathogens posing a significant threat due to their virulence and rapid development of drug-resistance.
  • The slight variation (+/-) between one experiment to the next is likely due to small variance in the sensitivity of the instruments used in detection.
  • Further to this designation, RECCE\xc2\xae 327 has been included on The Pew Charitable Trusts Global New Antibiotics in Development Pipeline as the only synthetic polymer and sepsis drug candidate in development.\nRecce wholly owns its automated manufacturing, ready to support first-in-human clinical trials.
  • Recce\xe2\x80\x99s anti-infective pipeline seeks to exploit the unique capabilities of RECCE\xc2\xae technologies targeting synergistic, unmet medical needs.\n"

Austral Gold Announces Filing of Q1 2021 Quarterly Activity Report

Friday, April 30, 2021 - 3:40pm

b'Sydney, Australia--(Newsfile Corp. - April 30, 2021) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (the "Company") is pleased to announce that it has filed its Q1 2021 Quarterly Activity Report.

Key Points: 
  • b'Sydney, Australia--(Newsfile Corp. - April 30, 2021) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (the "Company") is pleased to announce that it has filed its Q1 2021 Quarterly Activity Report.
  • The Report is available under the Company\'s profile at www.asx.com.au , www.sedar.com and on the Company\'s website at www.australgold.com .\nAustral Gold Limited is a growing gold and silver mining, development and exploration company building a portfolio of quality assets in Chile, the USA and Argentina.
  • Austral owns a 100% interest in the Guanaco/Amancaya mine in Chile and the Casposo Mine (currently on care and maintenance) in Argentina, and a non-controlling interest in the Rawhide Mine in Nevada, USA.
  • Austral Gold Limited is listed on the TSX Venture Exchange (TSX-V: AGLD) and the Australian Securities Exchange.

Immutep To Announce New TACTI-002 and INSIGHT-004 Data in Poster Presentations and Discussion at the ASCO 2021 Annual Meeting

Wednesday, April 28, 2021 - 3:21pm

For additional information on the 2021 ASCO\xe2\x80\x99s Annual meeting, please visit https://www.asco.org/\nTACTI-002 (Two ACTive Immunotherapies) is a Phase II clinical trial being conducted in collaboration with Merck & Co., Inc., Kenilworth, NJ, USA (known as \xe2\x80\x9cMSD\xe2\x80\x9d outside the United States and Canada).

Key Points: 
  • For additional information on the 2021 ASCO\xe2\x80\x99s Annual meeting, please visit https://www.asco.org/\nTACTI-002 (Two ACTive Immunotherapies) is a Phase II clinical trial being conducted in collaboration with Merck & Co., Inc., Kenilworth, NJ, USA (known as \xe2\x80\x9cMSD\xe2\x80\x9d outside the United States and Canada).
  • Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders.
  • Immutep is also developing an agonist of LAG-3 (IMP761) for autoimmune disease.
  • Additional LAG-3 products, including antibodies for immune response modulation, are being developed by Immutep\xe2\x80\x99s large pharmaceutical partners.\nFurther information can be found on the Company\xe2\x80\x99s website www.immutep.com or by contacting:\n'

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

Tuesday, April 27, 2021 - 1:30pm

This test kit requires no blood, and only a nasopharyngeal swab is needed to collect samples.

Key Points: 
  • This test kit requires no blood, and only a nasopharyngeal swab is needed to collect samples.
  • It can also deliver the test results within 10 minutes.
  • Getting the export authorization is an important achievement in our effort to overcome the coronavirus.
  • This new test kit can let testers know whether they have the antigen before the vaccination.

Austral Gold Annual General Meeting

Friday, April 23, 2021 - 5:18pm

b'Sydney, Australia--(Newsfile Corp. - April 23, 2021) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (\'the Company" or "Austral") is pleased to advise that the following documents were dispatched to shareholders today for its Annual General Meeting to be held on Thursday, 27 May, 2021 at 8:00am AEST in Sydney Australia:\nThe Notice of Annual General Meeting and the two sample Proxy Forms will be available at http://www.asx.com.au , on the Company\'s website at www.australgold.com and will be filed on Sedar under the Company\'s profile.\nAustral Gold Limited is a growing gold and silver mining, development and exploration company building a portfolio of quality assets in Chile, the USA and Argentina.

Key Points: 
  • b'Sydney, Australia--(Newsfile Corp. - April 23, 2021) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (\'the Company" or "Austral") is pleased to advise that the following documents were dispatched to shareholders today for its Annual General Meeting to be held on Thursday, 27 May, 2021 at 8:00am AEST in Sydney Australia:\nThe Notice of Annual General Meeting and the two sample Proxy Forms will be available at http://www.asx.com.au , on the Company\'s website at www.australgold.com and will be filed on Sedar under the Company\'s profile.\nAustral Gold Limited is a growing gold and silver mining, development and exploration company building a portfolio of quality assets in Chile, the USA and Argentina.
  • Austral owns a 100% interest in the Guanaco/Amancaya mine in Chile and the Casposo Mine (currently on care and maintenance) in Argentina, and a non-controlling interest in the Rawhide Mine in Nevada, USA.
  • Austral Gold Limited is listed on the TSX Venture Exchange (TSXV: AGLD) and the Australian Securities Exchange.
  • For more information, please consult Austral\'s website at www.australgold.com .\nRelease approved by the Chief Executive Officer of Austral Gold, Stabro Kasaneva.\nFor additional information please contact:\n'

Austral Gold Clarifies Notification of Dividend

Wednesday, April 21, 2021 - 4:41pm

b'Sydney, Australia--(Newsfile Corp. - April 21, 2021) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) ("Austral" or the "Company") advises that it had filed an updated Notification of Dividend on 23 February, 2021.\nAustral Gold Limited is a growing gold and silver mining, development and exploration company building a portfolio of quality assets in Chile, the USA and Argentina.

Key Points: 
  • b'Sydney, Australia--(Newsfile Corp. - April 21, 2021) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) ("Austral" or the "Company") advises that it had filed an updated Notification of Dividend on 23 February, 2021.\nAustral Gold Limited is a growing gold and silver mining, development and exploration company building a portfolio of quality assets in Chile, the USA and Argentina.
  • Austral owns a 100% interest in the Guanaco/Amancaya mine in Chile and the Casposo Mine (currently on care and maintenance) in Argentina, and a non-controlling interest in the Rawhide Mine in Nevada, USA.
  • Austral Gold Limited is listed on the TSX Venture Exchange (TSXV: AGLD) and the Australian Securities Exchange.
  • For more information, please consult Austral\'s website at www.australgold.com .\nRelease approved by the Chief Executive Officer of Austral Gold, Stabro Kasaneva.\nFor additional information please contact:\n'

$10.2 million Placement for Kharmagtai High Grade Exploration

Friday, April 23, 2021 - 12:37pm

The Joint Lead Managers have received commitments from certain institutional investors to purchase the Sell Down Shares.\nThe Placement is scheduled to settle on Friday, 30 April 2021 with allotment and trading to occur on Monday, 3 May 2021.

Key Points: 
  • The Joint Lead Managers have received commitments from certain institutional investors to purchase the Sell Down Shares.\nThe Placement is scheduled to settle on Friday, 30 April 2021 with allotment and trading to occur on Monday, 3 May 2021.
  • The Sell Down is scheduled to settle on or around 6 May 2021.\nArgonaut Securities Pty Limited and CLSA Australia Pty Ltd acted as Joint Lead Managers to the Placement.\nNon-Executive Chairman, Colin Moorhead, said, \xe2\x80\x9cWe are pleased with the strong support received from both existing shareholders and new institutional investors.
  • This Placement continues to strengthen our share register and fully funds Xanadu to execute its exploration strategy at Kharmagtai.
  • Investors can look forward to a period of strong exploration news flow as we embark on an aggressive drilling program to define the higher grade, gold-rich bornite zones at depth and unlock the next stage of development in this globally significant copper-gold project.\xe2\x80\x9d\n'